Akèy › Kansè aparèy respiratwa › Ohio › Columbus
Etid klinik pou Kansè aparèy respiratwa nan Columbus, OH
3 etid pou Kansè aparèy respiratwa ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Ap rekriteFaz 3
- Ohio State University Hospitals, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- The Ohio State University Wexner Medical Center, Columbus
Etid Kansè aparèy respiratwa nan lòt vil
- Houston, TX5 etid
- Boston, MA4 etid
- Chicago, IL3 etid
- Los Angeles, CA3 etid
- New York City, NY3 etid
- Arlington, VA3 etid
- Indianapolis, IN3 etid
Lòt etid nan Columbus
- Kansè Poumon ki pa ti selil57 etid
- Kansè nan tete40 etid
- Kansè ovè39 etid
- Kansè (tout kalite)38 etid
- Kansè poumon37 etid
- Leksemi mieloïd egi35 etid
- Lukemi lenfositè kwonik28 etid
- Kansè Metastatik27 etid
- Kansè Endomèt25 etid
- Kansè pwostat24 etid
- Myelom Miltip24 etid
- Kansè kolorektal24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.